EUVIMEDEUVIMED entdecken
Crossref

A UHPLC–MS/MS method for the simultaneous determination of vancomycin, norvancomycin, meropenem, and moxalactam in human plasma and its clinical application

Jiping Huo iD, Yangyang Guo, Bo Zhang, Zhigang Zhao, Guangzhi Shi, Shenghui Mei

Journal of Mass Spectrometry · 2023

DOI: 10.1002/jms.4925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Mass Spectrometry, 2023. Verfasst von Jiping Huo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Vancomycin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We developed an ultra‐high‐performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) method to determine four antibacterial drugs in human plasma for clinical usage. Samples were prepared using protein precipitation with methanol. Chromatographic separation was accomplished in 4.5 min on a BEH C18 column (2.1 × 50 mm, 1.7 μm) using a gradient elution of methanol and water (containing 7.71 g/L concentrated ammonium acetate, adjusted to pH 6.5 with acetic acid) at a flow rate of 0.4 mL/min. Positive electrospray was used for ionization. The method was linear in the concentration range 1–100 μg/mL for vancomycin, norvoncomycin, and meropenem; and 0.5–50 μg/mL for R‐isomer of moxalactam and S‐isomer of moxalactam. For all analytes, the intra‐ and inter‐day accuracies and precisions were −8.47%–10.13% and less than 12%, respectively. The internal standard normalized recoveries and matrix effect were 62.72%–105.78% and 96.67%–114.20%, respectively. All analytes were stable at six storage conditions, with variations of less than 15.0%. The method was applied in three patients with central nervous system infection. The validated method might be useful for routine therapeutic drug monitoring and pharmacokinetic study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryVancomycinHumansChromatography, High Pressure LiquidMeropenemMoxalactamMethanol

Stichwörter der Autor:innen

UHPLC-MS/MSmeropenemmoxalactamnorvancomycinvancomycin

Substanzen

norvancomycinVancomycinMeropenemMoxalactamMethanol

Autor:innen und Institutionen

  • Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
  • Intensive Care Unit, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Pharmacy, Beijing Health Vocational College, Beijing, China.

ORCID-Profile: Jiping Huo

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Huo, J., Guo, Y., Zhang, B., Zhao, Z., Shi, G., & Mei, S. (2023). A UHPLC–MS/MS method for the simultaneous determination of vancomycin, norvancomycin, meropenem, and moxalactam in human plasma and its clinical application. Journal of Mass Spectrometry. https://doi.org/10.1002/jms.4925

Vancouver

Huo J, Guo Y, Zhang B, Zhao Z, Shi G, Mei S. A UHPLC–MS/MS method for the simultaneous determination of vancomycin, norvancomycin, meropenem, and moxalactam in human plasma and its clinical application. Journal of Mass Spectrometry. 2023. doi:10.1002/jms.4925

BibTeX
@article{Huo2023,
  author = {Huo, Jiping and Guo, Yangyang and Zhang, Bo and Zhao, Zhigang and Shi, Guangzhi and Mei, Shenghui},
  title = {A UHPLC–MS/MS method for the simultaneous determination of vancomycin, norvancomycin, meropenem, and moxalactam in human plasma and its clinical application},
  journal = {Journal of Mass Spectrometry},
  year = {2023},
  doi = {10.1002/jms.4925}
}
Kostenlos starten →